| Page 1273 | Kisaco Research

Pets Testimonial 2022 Société Générale CIB

After 3 years of pandemic, great to get connected in physical with peers, academics,  and technology expert on PETs. Workshop a bit short in timing but really interesting especially discussion on the benefits but also the challenge and barriers PETs user may face.

Pets Testimonial 2022 MPC Alliance

For the first time over a few years, the main pioneers of secure computing were together in the same room. Very little time was left to breathe.

Pets Testimonial 2022 CEA LIST

I really appreciated the presentation of the business cases with PET. It highlights the challenges for PET integration.  

Pets Testimonial 2022 CipherMode Labs

I really enjoyed both the sessions and networking opportunities. It’s a small community so getting everyone in a room together is incredibly valuable 

Pets Testimonial 2022 Roche

Having the opportunity to learn from more advanced industries and explore own use case ideas with providers.

Pets Testimonial 2022 Lombard Odier

I've acquired basic knowledge about PETs and potential applications on use cases applicable in my industry.  I could also network and establish some relationships.

Pets Testimonial 2022 Swiss Re

It was great getting together with experts and solution providers, finally in-person, in order to exchange on PET and to learn about most recent developments.

Pets Testimonial 2022 Optalysys

I really enjoyed the diversity of attendees backgrounds ad work experience, from deep tech to customer-facing roles. One of the main challenges for the wide adoption of PETs is to connect people working on the technologies they rely on with those who develop or deploy concrete solutions, and this event was one of the rare an precious opportunities to do that.

 

Hooman Sedghamiz

Senior Director of AI & ML
Bayer

Hooman Sedghamiz is Director of AI & ML at Bayer. He has lead algorithm development and generated valuable insights to improve medical products ranging from implantable, wearable medical and imaging devices to bioinformatics and pharmaceutical products for a variety of multinational medical companies.

Hooman Sedghamiz

Senior Director of AI & ML
Bayer

Hooman Sedghamiz

Senior Director of AI & ML
Bayer

Hooman Sedghamiz is Director of AI & ML at Bayer. He has lead algorithm development and generated valuable insights to improve medical products ranging from implantable, wearable medical and imaging devices to bioinformatics and pharmaceutical products for a variety of multinational medical companies.

He has lead projects, data science teams and developed algorithms for closed loop active medical implants (e.g. Pacemakers, cochlear and retinal implants) as well as advanced computational biology to study the time evolution of cellular networks associated with cancer , depression and other illnesses.

His experience in healthcare also extends to image processing for Computer Tomography (CT), iX-Ray (Interventional X-Ray) as well as signal processing of physiological signals such as ECG, EMG, EEG and ACC.

Recently, his team has been working on cutting edge natural language processing and developed cutting edge models to address the healthcare challenges dealing with textual data.

 

Gordon Wilson

Co-Founder & CEO
Rain Neuromorphics

Gordon Wilson

Co-Founder & CEO
Rain Neuromorphics

Gordon Wilson

Co-Founder & CEO
Rain Neuromorphics